Medical diligence uncovers fallopian tube cancer after abnormal Pap test
BMJ case reports, 12(7), e229762
Abstract
The fallopian tube has received attention as an origin of high-grade pelvic malignancies. This is a case of bilateral fallopian tube cancer discovered after an abnormal Pap test. A 62-year-old woman with a history of one term delivery had atypical glandular cells on a Pap test. She had an unsatisfactory colposcopy and a normal transvaginal ultrasound. A loop electrode excision procedure and hysteroscopy with dilation and curettage revealed atypical glandular cells concentrated in floating balls. CA-125 was 10 U/mL. A robotic hysterectomy revealed histopathological stage IIIA serous carcinoma arising from both fallopian tubes. She received six cycles of carboplatin and paclitaxel. After chemotherapy, she has no evidence of disease at 5 years. Fallopian tube carcinoma is a differential diagnosis of abnormal glandular cells on a Pap test. Diagnosis by systematic pursuit of abnormal tests can lead to successful treatment of a small disease burden.
Topics
Cite this article
Cara Buskmiller, Cline, B., & Xynos, F. (2019). Medical diligence uncovers fallopian tube cancer after abnormal Pap test. *BMJ case reports*, *12*(7), e229762. https://doi.org/10.1136/bcr-2019-229762
Cara Buskmiller, Cline B, Xynos F. Medical diligence uncovers fallopian tube cancer after abnormal Pap test. BMJ Case Rep. 2019;12(7):e229762. doi:10.1136/bcr-2019-229762
Cara Buskmiller, et al. "Medical diligence uncovers fallopian tube cancer after abnormal Pap test." *BMJ case reports*, vol. 12, no. 7, 2019, pp. e229762.
Keywords
Carcinoma, Transitional Cell, Drug Therapy, Epithelial Cells, Fallopian Tube Neoplasms, Fallopian Tubes, Female, Humans, Hysterectomy, Middle Aged, Papanicolaou Test, Treatment Outcome, Cancer Intervention, Cervical Screening, Gynaecological Cancer, Obstetrics and Gynaecology, Screening (oncology)